2404176
Cooperative Agreement
Overview
Grant Description
Sbir phase ii: additive manufacturing for soft tissue repair by three-dimensional microfiber fabrication (3dmf) -the broader impact/commercial potential of this small business innovation research (sbir) phase ii project is to improve the outcomes for upwards of 500,000 americans each year who undergo shoulder soft tissue repair surgeries.
Shoulder repair surgeries have an unacceptably high failure rate of around 25% and lack effective, economical, and easy-to-use treatment options in this $7b market.
This nsf phase ii sbir campaign will develop a multi-axial filament winding process (3dmf) for robotically positioning biological materials to medical device implants.
3dmf implants will be made more rapidly and economically than existing technologies, with extraordinary biomechanical performance, and, importantly, designed for facile surgical use without additional tooling or fixation for delivery, based on extensive surgeon-guided inputs.
Upon commercialization, this technology will significantly reduce the cost of surgical implant augmentation and minimize surgical touch time, surgical complexity, and overall costs while providing a superior healing implant for challenging rotator cuff repairs.
This small business innovation research (sbir) phase ii project will biomanufacture 3dmf orthobiologic implants using human collagen resin and biopolymer yarns to form physiologically high-strength microfibrous implants that mimic native tissue strength and biology.
This research advances knowledge in the field, progressing beyond existing limited additive and fiber-based manufacturing technologies (i.e., electrospinning, weaving, braiding, 3d printing, etc.) to provide features critical for the end-user surgeon.
The work?s main objectives include: 1.) to biomanufacture quality-controlled 3dmf implants at the clinical scale; 2.) to optimize 3dmf arthroscopic surgical delivery and human factors, 3.) to determine 3dmf biomechanical performance, and 4.) to determine 3dmf device biocompatibility.
Completing this work will progress product development of the 3dmf device with proven manufacturability, yielding implants with the required strength and accessible surgical approach for facile implantation within the existing surgical workflow to drive commercial adoption and reimbursement.
This work specifically targets research and development of 3dmf implants for the rotator cuff repair niche with a large market with an unmet need for an accessible, economical, and effective solution.
This award reflects nsf's statutory mission and has been deemed worthy of support through evaluation using the foundation's intellectual merit and broader impacts review criteria.- subawards are not planned for this award.
Shoulder repair surgeries have an unacceptably high failure rate of around 25% and lack effective, economical, and easy-to-use treatment options in this $7b market.
This nsf phase ii sbir campaign will develop a multi-axial filament winding process (3dmf) for robotically positioning biological materials to medical device implants.
3dmf implants will be made more rapidly and economically than existing technologies, with extraordinary biomechanical performance, and, importantly, designed for facile surgical use without additional tooling or fixation for delivery, based on extensive surgeon-guided inputs.
Upon commercialization, this technology will significantly reduce the cost of surgical implant augmentation and minimize surgical touch time, surgical complexity, and overall costs while providing a superior healing implant for challenging rotator cuff repairs.
This small business innovation research (sbir) phase ii project will biomanufacture 3dmf orthobiologic implants using human collagen resin and biopolymer yarns to form physiologically high-strength microfibrous implants that mimic native tissue strength and biology.
This research advances knowledge in the field, progressing beyond existing limited additive and fiber-based manufacturing technologies (i.e., electrospinning, weaving, braiding, 3d printing, etc.) to provide features critical for the end-user surgeon.
The work?s main objectives include: 1.) to biomanufacture quality-controlled 3dmf implants at the clinical scale; 2.) to optimize 3dmf arthroscopic surgical delivery and human factors, 3.) to determine 3dmf biomechanical performance, and 4.) to determine 3dmf device biocompatibility.
Completing this work will progress product development of the 3dmf device with proven manufacturability, yielding implants with the required strength and accessible surgical approach for facile implantation within the existing surgical workflow to drive commercial adoption and reimbursement.
This work specifically targets research and development of 3dmf implants for the rotator cuff repair niche with a large market with an unmet need for an accessible, economical, and effective solution.
This award reflects nsf's statutory mission and has been deemed worthy of support through evaluation using the foundation's intellectual merit and broader impacts review criteria.- subawards are not planned for this award.
Awardee
Funding Goals
THE GOAL OF THIS FUNDING OPPORTUNITY, "NSF SMALL BUSINESS INNOVATION RESEARCH PHASE II (SBIR)/ SMALL BUSINESS TECHNOLOGY TRANSFER (STTR) PROGRAMS PHASE II", IS IDENTIFIED IN THE LINK: HTTPS://WWW.NSF.GOV/PUBLICATIONS/PUB_SUMM.JSP?ODS_KEY=NSF23516
Grant Program (CFDA)
Awarding / Funding Agency
Place of Performance
Tampa,
Florida
33612-9221
United States
Geographic Scope
Single Zip Code
Asante Bio was awarded
Cooperative Agreement 2404176
worth $979,298
from National Science Foundation in May 2024 with work to be completed primarily in Tampa Florida United States.
The grant
has a duration of 2 years and
was awarded through assistance program 47.084 NSF Technology, Innovation, and Partnerships.
The Cooperative Agreement was awarded through grant opportunity NSF Small Business Innovation Research / Small Business Technology Transfer Phase II Programs (SBIR/STTR Phase II).
SBIR Details
Research Type
SBIR Phase II
Title
SBIR Phase II: Additive Manufacturing for Soft Tissue Repair by Three-Dimensional Microfiber Fabrication (3DMF)
Abstract
The broader impact/commercial potential of this Small Business Innovation Research (SBIR) Phase II project is to improve the outcomes for upwards of 500,000 Americans each year who undergo shoulder soft tissue repair surgeries. Shoulder repair surgeries have an unacceptably high failure rate of around 25% and lack effective, economical, and easy-to-use treatment options in this $7B market. This NSF Phase II SBIR campaign will develop a multi-axial filament winding process (3DMF) for robotically positioning biological materials to medical device implants. 3DMF implants will be made more rapidly and economically than existing technologies, with extraordinary biomechanical performance, and, importantly, designed for facile surgical use without additional tooling or fixation for delivery, based on extensive surgeon-guided inputs. Upon commercialization, this technology will significantly reduce the cost of surgical implant augmentation and minimize surgical touch time, surgical complexity, and overall costs while providing a superior healing implant for challenging rotator cuff repairs.
This Small Business Innovation Research (SBIR) Phase II project will biomanufacture 3DMF orthobiologic implants using human collagen resin and biopolymer yarns to form physiologically high-strength microfibrous implants that mimic native tissue strength and biology. This research advances knowledge in the field, progressing beyond existing limited additive and fiber-based manufacturing technologies (i.e., electrospinning, weaving, braiding, 3D printing, etc.) to provide features critical for the end-user surgeon. The work’s main objectives include: 1.) To biomanufacture quality-controlled 3DMF implants at the clinical scale; 2.) To optimize 3DMF arthroscopic surgical delivery and human factors, 3.) to determine 3DMF biomechanical performance, and 4.) To determine 3DMF device biocompatibility. Completing this work will progress product development of the 3DMF device with proven manufacturability, yielding implants with the required strength and accessible surgical approach for facile implantation within the existing surgical workflow to drive commercial adoption and reimbursement. This work specifically targets research and development of 3DMF implants for the rotator cuff repair niche with a large market with an unmet need for an accessible, economical, and effective solution.
This award reflects NSF's statutory mission and has been deemed worthy of support through evaluation using the Foundation's intellectual merit and broader impacts review criteria.
Topic Code
MD
Solicitation Number
NSF 23-516
Status
(Ongoing)
Last Modified 5/6/24
Period of Performance
5/1/24
Start Date
4/30/26
End Date
Funding Split
$979.3K
Federal Obligation
$0.0
Non-Federal Obligation
$979.3K
Total Obligated
Activity Timeline
Additional Detail
Award ID FAIN
2404176
SAI Number
None
Award ID URI
SAI EXEMPT
Awardee Classifications
Small Business
Awarding Office
491503 TRANSLATIONAL IMPACTS
Funding Office
491503 TRANSLATIONAL IMPACTS
Awardee UEI
YFLQRVHCDKY1
Awardee CAGE
93H37
Performance District
FL-15
Senators
Marco Rubio
Rick Scott
Rick Scott
Modified: 5/6/24